Chemical Structure (G1x00 0001 01)
Cosela Injection, Powder, Lyophilized, For Solution
Product Images NDC 73462-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cosela (NDC 73462-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by G1 Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – 300 mg Vial Carton Label (G1x00 0001 02)
Cosela (trilaciclib) is a sterile lyophilized drug recommended for intravenous infusion after reconstitution and dilution. Each vial contains 300 mg/vial of trilaciclib which requires further dilution before administration. The dosage information must be followed as prescribed by the healthcare provider. The drug must be reconstituted with 19.5 mL of 0.9% Sodium Chloride Injection or 5% Dextrose Injection. Gl Therapeutics, Inc. distributes the drug, and it is manufactured in Finland. The drug is to be stored within the temperature range of 20°C to 25°C. The lot number, expiration date, and other essential details are available on the vial.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
